On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the Ohio-based contract manufacturing and research hybrid has hung up its hat for good. Amplify’s decision ...

Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy. The layoffs are expected to be ...

A New Jersey woman has been given a second chance at life, thanks to a new cancer therapy. Pamela Goldberger, 65, found out in 2023 that she had glioblastoma — a devastating diagnosis with an average ...

The symbiotic bacteria that live with reed beetles have different cell shapes in larvae than in adults. This image features these bacteria (in magenta) within the specialized organs of a larva and an ...

New research from Dana-Farber Cancer Institute shows that a new class of drug results in cell death in cancers, such as small cell lung cancer, with a disabled quality control cell cycle checkpoint ...

Aug 15 (Reuters) - In the latest setback for Pfizer's (PFE.N), opens new tab sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal in a late-stage trial for patients ...